Evidence map›Paper›PMID 31174238›Full record

ArticleCancer2019

Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: A model predicting local control and vetting of the eighth edition of the American Joint Committee on Cancer pathologic T stage.

Shaum Sridharan, Lester D R Thompson, Bibianna Purgina, Charles D Sturgis, Akeesha A Shah, Brian Burkey, Madalina Tuluc, David Cognetti, Bin Xu, Kevin Higgins and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Tumor Bed Margins Versus Specimen Margins in Oral Cavity Cancer: Too Close to Call?Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 3 countries.

Shaum SridharanDepartment of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Lester D R ThompsonDepartment of Pathology, Southern California Permanente Medical Group, Woodland Hills, California.
Bibianna PurginaDepartment of Pathology and Laboratory Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.
Charles D SturgisDepartment of Pathology, Cleveland Clinic, Cleveland, Ohio.
Akeesha A ShahDepartment of Pathology, Cleveland Clinic, Cleveland, Ohio.
Brian BurkeySection of Head and Neck Surgery and Oncology, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio.
Madalina TulucDepartment of Pathology, Thomas Jefferson University, Philadelphia, Pennsylvania.
David CognettiDepartment of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.
Bin XuDepartment of Pathology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Kevin HigginsDepartment of Otolaryngology-Head and Neck Surgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Juan C Hernandez-PreraDepartment of Anatomic Pathology, Moffitt Cancer Center, Tampa, Florida.
Dominick GuerreroDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York.
Manish M BundeleDepartment of Pathology, Tan Tock Seng Hospital, Singapore.
Seungwon KimDepartment of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Umamaheswar DuvvuriDepartment of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Robert L FerrisDepartment of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.ORCID 0000-0001-6605-2071
William E GoodingBiostatistics Facility, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
Simion I ChioseaDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.ORCID 0000-0002-5766-8779
University of Pittsburgh Medical Center · USCleveland Clinic · USSunnybrook Health Science Centre · CAThomas Jefferson University · USIcahn School of Medicine at Mount Sinai · USMoffitt Cancer Center · USTan Tock Seng Hospital · SGUniversity of Ottawa · CAUPMC Hillman Cancer Center · USWoodland Hills Medical Center · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTOPHER J. BAKKENIST · 1988 to 2026
$158.0M
Head and Neck SPORE P30CA047904NCI NIH HHS P30 CA047904University of Pittsburgh Medical Center Hillman Cancer Center Biostatistics Facility P30CA047904
6 · The paper itself

Abstract

backgroundThe eighth edition of the American Joint Committee on Cancer staging manual (AJCC8) added depth of invasion to the definition of pathologic T stage (pT). In the current study, the authors assess pT stage migration and the prognostic performance of the updated pT stage and compare it with other clinicopathologic variables in patients with early squamous cell carcinoma of the oral tongue (OTSCC; tumors measuring ≤4 cm) with histologically benign lymph nodes (pN0).

methodsA multi-institutional cohort of patients with early OTSCC was restaged as per AJCC8. Primary endpoints were local recurrence (LR) and locoregional recurrence (LRR). Influential variables were identified and an LR/LRR prediction model was developed.

resultsThere were a total of 494 patients, with 49 LR and 73 LRR. AJCC8 pT criteria resulted in upstaging of 37.9% of patients (187 of 494 patients), including 34.5% (64 of 185 patients) from pT2 to pT3, without improving the prognostication for LR or LRR. Both LR and LRR were found to be similar for patients with AJCC8 pT2 and pT3 disease. On multivariate analysis, LR was only found to be associated with distance to the closest margin (hazard ratio, 0.36; 95% CI, 0.20-0.64 [P = .0007]) and perineural invasion (hazard ratio, 1.92; 95% CI, 1.10-0.64 [P = .046]). Based on these 2 predictors, a final proportional hazards regression model (which may be used similar to a nomogram) was developed. The proposed model appeared to be superior to AJCC pT stage for estimating the probability of LR and LRR for individual patients with early OTSCC.

conclusionsAJCC8 pT criteria resulted in pT upstaging of patients with pN0 disease without improved LR or LRR prognostication. The proposed model based on distance to the closest margin and perineural invasion, status outperformed pT as a predictor of LR and LRR in patients with early OTSCC.

Indexed as

AdultAgedAged, 80 and overFemaleHead and Neck NeoplasmsHumansLymph NodesMaleMiddle AgedNeckNeoplasm InvasivenessNeoplasm Recurrence, LocalNeoplasm StagingPrognosisProportional Hazards ModelsSquamous Cell Carcinoma of Head and NeckAmerican Joint Committee on Cancer (AJCC) stagingdepth of invasionglossectomylocal disease recurrenceoral tonguepathologic T stage (pT)squamous cell carcinoma

Identifiers

PMID31174238
PMCPMC7723468
OpenAlexW2964720119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.